...
首页> 外文期刊>Journal of Medicinal Chemistry >Cloning, Expression, Post-Translational Modifications and Inhibition Studies on the Latest Mammalian Carbonic Anhydrase Isoform, CA XV
【24h】

Cloning, Expression, Post-Translational Modifications and Inhibition Studies on the Latest Mammalian Carbonic Anhydrase Isoform, CA XV

机译:最新的哺乳动物碳酸酐酶同工型,CA XV的克隆,表达,翻译后修饰和抑制研究

获取原文
获取原文并翻译 | 示例
           

摘要

We have cloned and purified to homogeneity the latest member of the mammalian alpha-carbonic anhydrase (CA, EC 4.2. 1.1) family, the mouse CA XV (mCA XV) protein. An investigation on the post-translational modifications of the enzyme has also been performed. The enzyme shows a moderate catalytic activity for the physiologic reaction, similarly to the physiologically relevant isoforms CA I, IV, VI, XII, and XIV, and it is susceptible to inhibition by sulfonamides and sulfamates. Best mCA XV inhibitors were celecoxib, sulfanilyl-sulfonamides, methazolamide, ethoxzolamide, dorzolamide, brinzolamide, and sulthiame, with K(I)s in the range of 45-65 nM. Due to the presence of this enzyme in rather high amounts in the rodent kidneys, the contribution of this isoform. to the overall drug response should be taken into account when animal models are used to investigate CA inhibitors.
机译:我们已经克隆并纯化了哺乳动物α-碳酸酐酶(CA,EC 4.2.1.1)家族的最新成员,即小鼠CA XV(mCA XV)蛋白。还对酶的翻译后修饰进行了研究。该酶对生理反应显示出适度的催化活性,类似于生理相关的同工型CA I,IV,VI,XII和XIV,并且易于被磺酰胺和氨基磺酸盐抑制。最佳的mCA XV抑制剂是塞来昔布,磺胺基磺酰胺,甲唑酰胺,乙氧唑酰胺,多佐胺,布林酰胺和舒阿米,K(I)的范围为45-65 nM。由于这种酶在啮齿动物肾脏中的含量很高,因此这种同工型的贡献。当使用动物模型研究CA抑制剂时,应考虑对总体药物反应的敏感性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号